SNORA80E and cancer: In addition, CD133+ cancer cells transfected with snoRA42-siRNA gave rise to significantly fewer mammospheres (Figure 3D) compared with CD133 + cancer cells treated with controls, implying the downregulation of snoRA42 decreased the capacity of mammosphere formation of TICs.